Pharmacy Can't Dodge Novo Nordisk's Diabetes Drug Suit

By Mike Curley · August 15, 2024, 7:18 PM EDT

A Tennessee federal judge on Thursday declined to throw out a suit by Novo Nordisk Inc. alleging that DCA Pharmacy is selling drugs with the same active ingredient as its Ozempic...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Novo Nordisk Inc. v. DCA Pharmacy

Case Number

3:23-cv-00668

Court

Tennessee Middle

Nature of Suit

Personal Property: Other

Date Filed

July 06, 2023